CSI Market
Sign In | Register

Metagenomi Therapeutics Inc (MGX) Annual Balance Sheets

Annual · GAAP · USD millions
Access MGX quarterly Balance Sheets →
The data below summarizes Metagenomi Therapeutics Inc's balance sheet position from to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024)
Assets
Cash & cash equivalent41.72
Available-for-sale Securities, Debt Securities, Current MA119.08
Cash & Short-term Investments160.00
Accounts receivable0.31
Prepaid Expense And Other Assets Current4.43
Total Current Assets165.54
Equipment/Property/Plant Net12.29
Long-term investments2.15
Other Assets, Noncurrent43.28
Operating Lease Right Of Use Asset35.09
Restricted Cash Noncurrent5.19
Total Assets221.10
Liabilities
Accounts Payable, Current AC1.49
Accrued Liabilities And Other Liabilities6.72
Other Liabilities, Current14.73
Total Current Liabilities22.93
Total Long-term Debt0.00
Other liabilities, Noncurrent39.57
Operating Lease Liability Current6.03
Contract With Customer Liability Current8.70
Operating Lease Liability Noncurrent34.63
Contract With Customer Liability Noncurrent2.99
Total Liabilities62.51
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock469.20
Retained Earnings / Accumulated Deficit-310.87
Other Equity0.26
Common Stockholder's Equity158.60
Total Stockholder's Equity158.60
Liabilities & Stockholder's Equity221.10
4 historic quarters locked

Sign in to unlock the full Metagenomi Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Metagenomi Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 5, 2026
  • Source: mgx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-093976

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License